PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
35.46%
Revenue growth above 1.5x RUN's 3.65%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
-171.55%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-922.43%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-930.10%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-948.31%
Negative net income growth while RUN stands at 111.99%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-946.15%
Negative EPS growth while RUN is at 111.54%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-943.59%
Negative diluted EPS growth while RUN is at 107.69%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.00%
Share reduction more than 1.5x RUN's 0.71%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.07%
Slight or no buyback while RUN is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
279.96%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
19.65%
Positive FCF growth while RUN is negative. John Neff would see a strong competitive edge in net cash generation.
58.55%
10Y revenue/share CAGR at 50-75% of RUN's 81.18%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-17.44%
Negative 5Y CAGR while RUN stands at 81.18%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-46.77%
Negative 3Y CAGR while RUN stands at 81.18%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
23.68%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
-71.13%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-63.14%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-6403.77%
Negative 10Y net income/share CAGR while RUN is at 264.20%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-234.35%
Negative 5Y net income/share CAGR while RUN is 264.20%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-497.53%
Negative 3Y CAGR while RUN is 264.20%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-91.06%
Negative equity/share CAGR over 10 years while RUN stands at 85.97%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-87.75%
Negative 5Y equity/share growth while RUN is at 85.97%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-91.23%
Negative 3Y equity/share growth while RUN is at 85.97%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.19%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-13.57%
Inventory is declining while RUN stands at 49.12%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-15.77%
Negative asset growth while RUN invests at 5.65%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-74.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-24.22%
We’re deleveraging while RUN stands at 13.93%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.20%
Our R&D shrinks while RUN invests at 12.73%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
6.03%
We expand SG&A while RUN cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.